School of Pharmacy, University of Otago , Dunedin , New Zealand.
Clin Toxicol (Phila). 2013 Sep-Oct;51(8):772-6. doi: 10.3109/15563650.2013.830733. Epub 2013 Aug 22.
There is contention over whether reported dose correlates with toxicity in paracetamol poisoning and risk assessment is currently based on serum paracetamol concentration compared to a nomogram, irrespective of reported dose. Objective. To determine if reported dose predicts the need for N-acetylcysteine (NAC).
Data were taken from paracetamol overdoses presenting to a tertiary toxicology service. Age, sex, reported dose, ingestion time, timed paracetamol concentrations between 4 and 16 h, hepatotoxicity (peak alanine transaminase > 1000 U/L) and treatment (single dose-activated charcoal [SDAC] and NAC) were analysed. Data were analysed within a repeated measures logistic regression framework using NONMEM (ver 7.2). The primary outcome was administration of NAC, which was determined based on a serum paracetamol concentration greater than the nomogram line.
There were 1571 admissions in 1303 patients, with a median age of 27 years (12-96 years) and 1140 (73%) were females. The median dose was 10 g (1-100 g). The paracetamol concentration was above the nomogram line in 337 of 1571 (22%) patients. Patients presenting later (first paracetamol concentration between 7 and 16 h post-overdose) compared to those presenting earlier (4-7 h post-overdose) were more likely to have hepatotoxicity (5.5% vs. 0.4%; p < 0.0001), have a toxic paracetamol concentration (34% vs. 18%; p < 0.0001) and receive NAC (48% vs. 23%; p < 0.0001). SDAC reduced the probability of the paracetamol concentration being above the nomogram. Based on SDAC not being administered there was a 5% probability of requiring NAC at a dose of 6-9 g, a 10% chance of requiring NAC at a dose of 13-16 g, a 50% chance of requiring NAC at a dose of 30-34 g and a 90% chance for needing NAC at 48-50 g.
Reported dose was a good predictor of a toxic paracetamol concentration and SDAC reduced the probability of the concentration being above the nomogram. These predictions may assist in determining which patients could be started on NAC immediately.
关于报告剂量与对乙酰氨基酚中毒毒性之间的相关性存在争议,目前的风险评估是基于与列线图相比血清对乙酰氨基酚浓度,而不考虑报告剂量。目的:确定报告剂量是否可预测是否需要使用 N-乙酰半胱氨酸(NAC)。
从三级毒理学服务机构收治的对乙酰氨基酚过量患者中获取数据。分析年龄、性别、报告剂量、摄入时间、4 至 16 小时时的定时对乙酰氨基酚浓度、肝毒性(峰值丙氨酸转氨酶 > 1000 U/L)和治疗(单次剂量活性炭[SDAC]和 NAC)。使用 NONMEM(版本 7.2)在重复测量逻辑回归框架内分析数据。主要结局是给予 NAC,这是基于血清对乙酰氨基酚浓度超过列线图而确定的。
1303 例患者中有 1571 例住院,中位年龄为 27 岁(12-96 岁),1140 例(73%)为女性。中位剂量为 10 g(1-100 g)。1571 例患者中有 337 例(22%)的对乙酰氨基酚浓度超过列线图。与较早(4-7 小时)相比,较晚(7-16 小时)就诊的患者更有可能发生肝毒性(5.5% vs. 0.4%;p < 0.0001),出现毒性对乙酰氨基酚浓度(34% vs. 18%;p < 0.0001)和接受 NAC(48% vs. 23%;p < 0.0001)。SDAC 降低了列线图上对乙酰氨基酚浓度超过的概率。根据未给予 SDAC,剂量为 6-9 g 时需要 NAC 的概率为 5%,剂量为 13-16 g 时需要 NAC 的概率为 10%,剂量为 30-34 g 时需要 NAC 的概率为 50%,剂量为 48-50 g 时需要 NAC 的概率为 90%。
报告剂量是对乙酰氨基酚毒性浓度的良好预测指标,SDAC 降低了浓度超过列线图的概率。这些预测结果可能有助于确定哪些患者可以立即开始使用 NAC。